Literature DB >> 29981035

Protecting the public from exposure to secondhand cannabis smoke and vapour following legalization.

Geoffrey McKee1, Shelley McClure2, Murray Fyfe3,2, Richard Stanwick2.   

Abstract

The adverse effects of direct cannabis use are well described in the literature; however, researchers are now beginning to expose the health consequences of secondhand exposure. Given the commitment by the federal government to legalize cannabis in Canada by summer 2018, public health officials must build on the successes of existing smoke-free programs and work with provinces and municipalities to develop policies that protect the public from secondhand exposure to cannabis smoke and vapour. While harmonization with existing tobacco laws may offer the simplest approach, other alternatives may allow stricter control of public consumption by different levels of government. Further research will be needed to assess the health implications of secondhand cannabis exposure, as well as the population impacts of legalization.

Entities:  

Keywords:  Cannabis; Inhalation exposure; Public policy

Mesh:

Substances:

Year:  2018        PMID: 29981035     DOI: 10.17269/s41997-018-0054-5

Source DB:  PubMed          Journal:  Can J Public Health        ISSN: 0008-4263


  3 in total

1.  "Where does the high road lead?" Potential implications of cannabis legalization for pediatric injuries in Canada.

Authors:  Mojgan Karbakhsh; Jennifer Smith; Ian Pike
Journal:  Can J Public Health       Date:  2018-09-27

2.  New Challenges: Developing Gendered and Equitable Responses to Involuntary Exposures to Electronic Nicotine Delivery Systems (ENDS) and Cannabis Vaping.

Authors:  Natalie Hemsing; Lorraine Greaves
Journal:  Int J Environ Res Public Health       Date:  2018-09-25       Impact factor: 3.390

3.  Tobacco Industry Efforts to Respond to Smoke-Free Policies in Multi-Unit Housing: An Evaluation of Tobacco Industry Documents.

Authors:  Joshua Miller; Maya Vijayaraghavan
Journal:  Int J Environ Res Public Health       Date:  2022-03-05       Impact factor: 3.390

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.